Get the Stockscreener App
1.92
1.05%
0.02
Elutia Inc stock is traded at $1.92, with a volume of 18,367.
It is up +1.05% in the last 24 hours and up +6.08% over the past month.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
See More
Previous Close:
$1.90
Open:
$1.93
24h Volume:
18,367
Relative Volume:
0.62
Market Cap:
$70.66M
Revenue:
$24.38M
Net Income/Loss:
$-53.95M
P/E Ratio:
-0.7773
EPS:
-2.47
Net Cash Flow:
$-23.31M
1W Performance:
-9.22%
1M Performance:
+6.08%
6M Performance:
-38.66%
1Y Performance:
-48.80%
1-Day Range:
$1.92
$2.02
1-Week Range:
$1.85
$2.25
52-Week Range:
$1.61
$5.12
Elutia Inc Stock (ELUT) Company Profile
Name
Elutia Inc
Sector
Industry
Phone
240-247-1143
Address
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
1.92 | 78.12M | 24.38M | -53.95M | -23.31M | -2.47 |
|
ABT
Abbott Laboratories
|
126.54 | 218.59B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.14 | 157.13B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
403.53 | 151.59B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.94 | 118.29B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
80.00 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-02-20 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-02-20 | Initiated | Cowen | Outperform |
| Nov-02-20 | Initiated | Piper Sandler | Overweight |
| Nov-02-20 | Initiated | Truist | Buy |
Elutia Inc Stock (ELUT) Latest News
What analysts say about Elutia Inc. stockSuperior profit margins - PrintWeekIndia
Is Elutia Inc. a good long term investmentFree Investment Community - PrintWeekIndia
Elutia Inc. Stock Analysis and ForecastOutperformance with explosive growth - Autocar Professional
What drives Elutia Inc. stock priceHigh-performance investment picks - jammulinksnews.com
KAPA Stock Analysis and ForecastFree Stock Index Interpretation - jammulinksnews.com
Is TENB a good long term investmentHigh-yield investments - jammulinksnews.com
What makes Elutia Inc. stock price move sharplyRisk Controlled Trading Ideas - Newser
WEAV Stock Analysis and ForecastPowerful growth strategies - jammulinksnews.com
[Latest] Global Cardiac Tissue Engineering Market Size/Share Worth USD 2,943.92 Million by 2034 at a 16.65% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Yahoo Finance
MSPRW Stock Analysis and ForecastExceptional market positioning - Jammu Links News
What analysts say about FatPipe Inc. stockGame-changing returns - jammulinksnews.com
What drives Middlesex Water Company stock priceSkyrocketing profit margins - jammulinksnews.com
Best Growth Stocks Stock Market Research ExpertsSkyrocketing investment returns - jammulinksnews.com
What analysts say about AnaptysBio Inc. stockMassive wealth growth - jammulinksnews.com
Why Elutia Inc. stock attracts strong analyst attentionQuick Profit Idea Stream - Newser
How Elutia Inc. stock performs during market volatilityFree Expert Investment Advice - Newser
Elutia (NASDAQ:ELUT) Trading Down 2.5% – Here’s What Happened - Defense World
Elutia Inc. Announces Promising Study Results for EluPro BioEnvelope in Improving Healing Outcomes for Cardiac Implantable Electronic Devices - Nasdaq
Clinical Study: Revolutionary Antibiotic Technology Shows Superior Results for Heart Implants - Stock Titan
Elutia announces publication of new study on CIED biologic envelope - TipRanks
Elutia Wins Dual Honors for Innovation and Product Launches at 2025 Medical Device Network Excellence Awards - GlobeNewswire
Medical Device Network Excellence Awards 2025: Elutia - Medical Device Network
Medical Device Breakthrough: Elutia's EluPro Wins Innovation Awards After 84% Sales Growth - Stock Titan
Revenues Working Against Elutia Inc.'s (NASDAQ:ELUT) Share Price - simplywall.st
Elutia Inc. (NASDAQ:ELUT) Shares Purchased by Millennium Management LLC - Defense World
Citadel Advisors LLC Acquires Shares of 22,431 Elutia Inc. (NASDAQ:ELUT) - Defense World
Brokers Issue Forecasts for Elutia FY2026 Earnings - Defense World
Elutia (NASDAQ:ELUT) Shares Down 1% – Time to Sell? - Defense World
Aziyo Biologics Holds Annual Stockholders Meeting - TipRanks
CANTOR FITZGERALD REITERATES ELUTIA STOCK RATING WITH $7 TARGET By Investing.com - Investing.com South Africa
CANTOR FITZGERALD REITERATES ELUTIA STOCK RATING WITH $7 TARGET - Investing.com
Elutia Inc Stock (ELUT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Elutia Inc Stock (ELUT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HighCape Capital, L.P. | Director |
Feb 03 '25 |
Buy |
2.50 |
420,000 |
1,050,000 |
9,520,232 |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER |
Jul 31 '24 |
Option Exercise |
1.43 |
105,080 |
150,002 |
257,823 |
1.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):